Literature DB >> 10652615

Cytotoxic intraepithelial lymphocytes in colorectal polyps and carcinomas.

C A Rubio1, B Jacobsson, E Castaños-Velez.   

Abstract

The frequency of intraepithelial lymphocytes (IEL) was investigated in 255 colorectal lesions: in 18 metaplastic polyps, in 159 tubular, serrated and villous adenomas, in 28 incipient adenocarcinomas and in 50 overt adenocarcinomas. > or = 21 IELs were found in 13.6% (12/88) of the adenomas with high grade dysplasia (HGD) but in none of the 18 metaplastic polyps, the 71 adenomas with low grade dysplasia (LGD), or the 50 overt adenocarcinomas. CD3-T, MHCII and TIA1 cell antigens were positive in IELs from tubular adenomas, villous adenomas, incipient carcinomas and overt adenocarcinomas. In the normal colorectal mucosa and in metaplastic polyps, CD3-T was positive whereas MHCII and TIA 1 were not expressed. On the other hand, Fas cell antigen was expressed in the normal mucosa and in metaplastic polyps but it was downregulated in neoplastic lesions. The upregulation of CD3-T, MHC class II molecules, and TIA 1 in IELs of neoplastic colorectal lesions suggests that they are activated and cytotoxic; however, they undergo apoptosis due to the downregulation of the FAS molecules.

Entities:  

Mesh:

Year:  1999        PMID: 10652615

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  The Fas-FasL system and colorectal tumours.

Authors:  C A Rubio; B Jacobsson
Journal:  J Clin Pathol       Date:  2002-07       Impact factor: 3.411

2.  Immune environment in serrated lesions of the colon: intraepithelial lymphocyte density, PD-1, and PD-L1 expression correlate with serrated neoplasia pathway progression.

Authors:  Gabriel Acosta-Gonzalez; Madhu Ouseph; Kara Lombardo; Shaolei Lu; Jonathan Glickman; Murray B Resnick
Journal:  Hum Pathol       Date:  2018-08-31       Impact factor: 3.466

3.  Adenoma-infiltrating lymphocytes (AILs) are a potential marker of hereditary nonpolyposis colorectal cancer.

Authors:  Alexandros D Polydorides; Bhramar Mukherjee; Stephen B Gruber; Barbara J McKenna; Henry D Appelman; Joel K Greenson
Journal:  Am J Surg Pathol       Date:  2008-11       Impact factor: 6.394

4.  TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.

Authors:  Inti Zlobec; Eva Karamitopoulou; Luigi Terracciano; Salvatore Piscuoglio; Giandomenica Iezzi; Manuele Giuseppe Muraro; Giulio Spagnoli; Kristi Baker; Alexandar Tzankov; Alessandro Lugli
Journal:  PLoS One       Date:  2010-12-10       Impact factor: 3.240

5.  Inflammatory response in serrated precursor lesions of the colon classified according to WHO entities, clinical parameters and phenotype-genotype correlation.

Authors:  Tilman T Rau; Raja Atreya; Daniela Aust; Gustavo Baretton; Matthias Eck; Katharina Erlenbach-Wünsch; Arndt Hartmann; Alessandro Lugli; Robert Stöhr; Michael Vieth; Anna M Wirsing; Inti Zlobec; Tiemo Katzenberger
Journal:  J Pathol Clin Res       Date:  2016-02-25

6.  Clinical Impact of X-Ray Repair Cross-Complementary 1 (XRCC1) and the Immune Environment in Colorectal Adenoma-Carcinoma Pathway Progression.

Authors:  Yu Zhang; Xin Zhang; Zhuoyi Jin; Huiyan Chen; Chenjing Zhang; Wangyue Wang; Jiyong Jing; Wensheng Pan
Journal:  J Inflamm Res       Date:  2021-10-20

7.  Apoptosis in human tumours.

Authors:  C A Rubio
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

8.  Fas ligand expression in lynch syndrome-associated colorectal tumours.

Authors:  Jan J Koornstra; Steven de Jong; Wietske Boersma-van Eck; Nynke Zwart; Harry Hollema; Elisabeth G E de Vries; Jan H Kleibeuker
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.